18 Dec 2025

HCPC launches sector-wide consent principles to enhance patient safety

The new consent principles are designed to raise awareness of what informed consent means and place patients at the heart of decision-making about their treatment

HCPC, with a cross-sector working group including the Nursing and Midwifery Council (NMC), General Pharmaceutical Council (GPhC), General Optical Council (GOC), General Osteopathic Council (GOsC), the Patient Safety Commissioner, the Patients Association, and the Council of Deans for Health, has launched a set of Consent Principles aimed at improving informed decision-making and reducing patient and service user harm.

Other regulators, including the General Medical Council (GMC),  the General Dental Council (GDC) and the General Medical Council (GCC), also support the work.

Developed with a cross-sector working group, these principles respond to ongoing patient safety concerns relating to consent and seek to support calls for a ‘patient-controlled system’ as set out in the NHS 10‑Year ‘Fit for the Future’ plan for England, as well as supporting the work being done on this issue across Scotland, Wales and Northern Ireland.

The principles do not seek to supersede existing standards but draw attention to them and apply to all HCPC-registered members, wherever they work.

The five consent principles

  1. Start with shared decision making
    The process starts with unbiased conversations about all reasonable options available to patients, including their potential risks and benefits, and the option to take no action. This discussion should include expected outcomes for varying options to support a shared understanding between patient and practitioner about the expectations and limitations of the available options.
     
  2. Individualise the risks and benefits
    Risks and benefits should be individualised to the (clinical and personal) circumstances of the individual patient and communicated in a way that supports understanding, including what risk (s) they would be prepared to take in order to achieve a desired outcome. Patients should be supported to consider the options in the context of their own lives and their preferences and values. When a patient is not able to consent or understand the risks and benefits, conversations about options should involve the family, friends of the patient or advocate.
     
  3. Ensure it is a continuous process
    Decision-making and consent should be seen as a continuous process which may be distributed between multiple professionals across time and location, through which a patient can fully understand the options available to them, is supported to deliberate on these options and then freely give their consent to proceed with their chosen course of action, unless the decision is to take no action. Some patients may be supported by their friends or family or have someone making decisions on their behalf.
     
  4. Conclude with consent
    Once a decision has been reached through shared decision-making, there should follow a conversation that confirms this decision, answers any outstanding questions and provides any additional information required (including any risks that the patient is likely to attach significance to not previously discussed).
     
  5. Patients are equal partners
    Patients are equal partners and active participants in the decision-making and consent process. Practitioners should encourage and support patients to ask questions and share their thoughts and opinions. Patients should not be pressured into making any decision and they should be free to change their mind at any stage. Consent is given by patients, not taken by practitioners.

The HCPC’s complete guidance on consent and confidentiality can be found here.

 To find out more about best practice in biomedical science, read our guidance: 

 

Related topics